GNRH1 and neoplasm: Even when LHRH ligands bind efficiently at the tumor surface, internalization and intracellular drug release must be precisely coordinated with endosomal trafficking and linker cleavage; suboptimal timing or premature release can reduce effective intratumoral drug concentration.